TR199701121T1 - Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri. - Google Patents

Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.

Info

Publication number
TR199701121T1
TR199701121T1 TR97/01121T TR9701121T TR199701121T1 TR 199701121 T1 TR199701121 T1 TR 199701121T1 TR 97/01121 T TR97/01121 T TR 97/01121T TR 9701121 T TR9701121 T TR 9701121T TR 199701121 T1 TR199701121 T1 TR 199701121T1
Authority
TR
Turkey
Prior art keywords
benazepril
valsartan
compositions containing
combination compositions
formula
Prior art date
Application number
TR97/01121T
Other languages
English (en)
Turkish (tr)
Inventor
De Gasparo Marc
Lee Webb Randy
Saul Cohen David
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR199701121T1 publication Critical patent/TR199701121T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR97/01121T 1995-04-07 1996-04-02 Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri. TR199701121T1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07

Publications (1)

Publication Number Publication Date
TR199701121T1 true TR199701121T1 (xx) 1998-03-21

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01121T TR199701121T1 (xx) 1995-04-07 1996-04-02 Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.

Country Status (15)

Country Link
EP (1) EP0820302A1 (cs)
JP (1) JPH11503139A (cs)
KR (1) KR19980703647A (cs)
CN (1) CN1181019A (cs)
AU (1) AU5399096A (cs)
BR (1) BR9604818A (cs)
CA (1) CA2214143A1 (cs)
CZ (1) CZ313897A3 (cs)
HU (1) HUP9801593A2 (cs)
MX (1) MX9707683A (cs)
NO (1) NO974400L (cs)
PL (1) PL322529A1 (cs)
SK (1) SK133897A3 (cs)
TR (1) TR199701121T1 (cs)
WO (1) WO1996031234A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835106A4 (en) * 1995-06-30 1998-09-30 Merck & Co Inc METHOD OF TREATING NEPHROPATHIES USING AN ACE INHIBITOR AND AN A II ANTAGONIST
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
CZ20023381A3 (cs) * 2000-04-12 2003-02-12 Novartis Ag Kombinované farmaceutické prostředky obsahující antagonistu AT1-receptoru nebo/a inhibitor HMG-CoA reduktázy nebo/a ACE inhibitor
DE60135560D1 (de) 2000-07-19 2008-10-09 Novartis Ag Valsartan salze
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
UY26893A1 (es) * 2000-08-22 2002-03-22 Boehringer Ingelheim Pharma Combinación farmacéutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversión de la angiotensina i
CA2432638A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
JP2006516020A (ja) * 2002-08-28 2006-06-15 キュリス インコーポレイテッド 慢性腎不全の治療におけるモルフォゲン及びace阻害薬の共投与
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
EP2432452B1 (de) 2009-05-20 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Pharmazeutische telmisartan-trinklösung
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
AU2015210898A1 (en) * 2014-01-31 2016-07-28 Janssen Pharmaceutica Nv Methods for the treatment and prevention of renal disorders and fatty liver disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2147875C1 (ru) * 1990-05-11 2000-04-27 Пфайзер Инк. Способ и композиция для снижения кровяного давления и лечения застойной сердечной недостаточности у млекопитающего
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
SK133897A3 (en) 1998-02-04
WO1996031234A1 (en) 1996-10-10
CN1181019A (zh) 1998-05-06
KR19980703647A (ko) 1998-12-05
EP0820302A1 (en) 1998-01-28
HUP9801593A2 (hu) 1999-01-28
BR9604818A (pt) 1998-06-09
MX9707683A (es) 1997-12-31
JPH11503139A (ja) 1999-03-23
NO974400D0 (no) 1997-09-23
CA2214143A1 (en) 1996-10-10
NO974400L (no) 1997-09-23
PL322529A1 (en) 1998-02-02
CZ313897A3 (cs) 1998-01-14
AU5399096A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
DE69531457D1 (en) Sulfonamide
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
MY125150A (en) Factor vlla inhibitors
BR9914044A (pt) ésteres tetrahidropirido
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
MY132705A (en) Novel compounds with analgesic effect
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
CA2216796A1 (en) Quinazoline derivatives
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
ID23504A (id) Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya
WO1996001253A3 (en) PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
BR9913285A (pt) Método de modulação das células t efetoras da memória e composições
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
AU1945495A (en) Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
GB9420747D0 (en) 1,5 benzodiazepine derivatives
HUP9801894A2 (hu) Dofetilid alkalmazása kongesztív szívpanaszok kezelésére szolgáló gyógyszerkészítmények előállítására
FR2754824B1 (fr) Nouvelle composition contenant du chitosan